ID   ARY1_HUMAN              Reviewed;         290 AA.
AC   P18440; A8K4E7; O15159; O15300; Q546N1; Q96TE9;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 2.
DT   15-FEB-2017, entry version 172.
DE   RecName: Full=Arylamine N-acetyltransferase 1;
DE            EC=2.3.1.5;
DE   AltName: Full=Arylamide acetylase 1;
DE   AltName: Full=Monomorphic arylamine N-acetyltransferase;
DE            Short=MNAT;
DE   AltName: Full=N-acetyltransferase type 1;
DE            Short=NAT-1;
GN   Name=NAT1; Synonyms=AAC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE NAT1*4).
RC   TISSUE=Leukocyte;
RX   PubMed=2340091; DOI=10.1089/dna.1990.9.193;
RA   Blum M., Grant D.M., McBride W., Heim M., Meyer U.A.;
RT   "Human arylamine N-acetyltransferase genes: isolation, chromosomal
RT   localization, and functional expression.";
RL   DNA Cell Biol. 9:193-203(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS NAT1*5 THR-117 AND
RP   166-THR-GLN-167.
RC   TISSUE=Liver;
RX   PubMed=1968463;
RA   Ohsako S., Deguchi T.;
RT   "Cloning and expression of cDNAs for polymorphic and monomorphic
RT   arylamine N-acetyltransferases from human liver.";
RL   J. Biol. Chem. 265:4630-4634(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS NAT1*11 ILE-149 AND
RP   ALA-214.
RX   PubMed=8442668; DOI=10.1006/abbi.1993.1116;
RA   Vatsis K.P., Weber W.W.;
RT   "Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1
RT   gene locus.";
RL   Arch. Biochem. Biophys. 301:71-76(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS NAT1*11 ILE-149 AND
RP   ALA-214.
RC   TISSUE=Blood;
RX   PubMed=9168895; DOI=10.1006/bbrc.1997.6501;
RA   Doll M.A., Jiang W., Deitz A.C., Rustan T.D., Hein D.W.;
RT   "Identification of a novel allele at the human NAT1 acetyltransferase
RT   locus.";
RL   Biochem. Biophys. Res. Commun. 233:584-591(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS NAT1*17 TRP-64 AND
RP   NAT1*14 GLN-187.
RX   PubMed=9511183;
RA   Butcher N.J., Ilett K.F., Minchin R.F.;
RT   "Functional polymorphism of the human arylamine N-acetyltransferase
RT   type 1 gene caused by C190T and G560A mutations.";
RL   Pharmacogenetics 8:67-72(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Deitz A.C., Fretland A.J., Leff M.A., Doll M.A., Hein D.W.;
RT   "Homo sapiens N-acetyltransferase-1 (NAT1) gene complete cds.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10862520; DOI=10.1097/00008571-200006000-00003;
RA   Lo-Guidice J.-M., Allorge D., Chevalier D., Debuysere H., Fazio F.,
RA   Lafitte J.-J., Broly F.;
RT   "Molecular analysis of the N-acetyltransferase 1 gene (NAT1*) using
RT   polymerase chain reaction-restriction fragment-single strand
RT   conformation polymorphism assay.";
RL   Pharmacogenetics 10:293-300(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS NAT1*11 ILE-149 AND
RP   ALA-214.
RA   Johnson N., Sim E.;
RT   "Homo sapiens arylamine N-acetyltransferase type 1 (NAT1) gene, allele
RT   NAT1*11B.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE NAT1*4).
RA   Johnson N., Sim E.;
RT   "Homo sapiens arylamine N-acetyltransferase type 1 (NAT1) gene, NAT1*4
RT   allele.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS NAT1*11 ILE-149 AND
RP   ALA-214.
RX   PubMed=16416399; DOI=10.1086/500614;
RA   Patin E., Barreiro L.B., Sabeti P.C., Austerlitz F., Luca F.,
RA   Sajantila A., Behar D.M., Semino O., Sakuntabhai A., Guiso N.,
RA   Gicquel B., McElreavey K., Harding R.M., Heyer E., Quintana-Murci L.;
RT   "Deciphering the ancient and complex evolutionary history of human
RT   arylamine N-acetyltransferase genes.";
RL   Am. J. Hum. Genet. 78:423-436(2006).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-149 AND ALA-214.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RC   TISSUE=Liver;
RX   PubMed=1676262; DOI=10.1016/0006-291X(91)90676-X;
RA   Ebisawa T., Deguchi T.;
RT   "Structure and restriction fragment length polymorphism of genes for
RT   human liver arylamine N-acetyltransferases.";
RL   Biochem. Biophys. Res. Commun. 177:1252-1257(1991).
RN   [15]
RP   MUTAGENESIS OF ARG-64.
RX   PubMed=9173883; DOI=10.1042/bj3230207;
RA   Delomenie C., Goodfellow G.H., Krishnamoorthy R., Grant D.M.,
RA   Dupret J.-M.;
RT   "Study of the role of the highly conserved residues Arg9 and Arg64 in
RT   the catalytic function of human N-acetyltransferases NAT1 and NAT2 by
RT   site-directed mutagenesis.";
RL   Biochem. J. 323:207-215(1997).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF WILD-TYPE IN COMPLEX WITH
RP   2-BROMOACETANILIDE AND OF MUTANT SER-125, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17656365; DOI=10.1074/jbc.M704138200;
RA   Wu H., Dombrovsky L., Tempel W., Martin F., Loppnau P.,
RA   Goodfellow G.H., Grant D.M., Plotnikov A.N.;
RT   "Structural basis of substrate-binding specificity of human arylamine
RT   N-acetyltransferases.";
RL   J. Biol. Chem. 282:30189-30197(2007).
RN   [18]
RP   ALLELE NAT1*10.
RX   PubMed=7585580;
RA   Bell D.A., Badawi A.F., Lang N.P., Ilett K.F., Kadlubar F.F.,
RA   Hirvonen A.;
RT   "Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation
RT   signal: association of NAT1*10 allele with higher N-acetylation
RT   activity in bladder and colon tissue.";
RL   Cancer Res. 55:5226-5229(1995).
RN   [19]
RP   VARIANT NAT1*14 GLN-187.
RX   PubMed=9511182;
RA   Hughes N.C., Janezic S.A., McQueen K.L., Jewett M.A., Castranio T.,
RA   Bell D.A., Grant D.M.;
RT   "Identification and characterization of variant alleles of human
RT   acetyltransferase NAT1 with defective function using p-aminosalicylate
RT   as an in-vivo and in-vitro probe.";
RL   Pharmacogenetics 8:55-66(1998).
RN   [20]
RP   VARIANTS NAT1*17; NAT1*21; NAT1*22; NAT1*24 AND NAT1*25.
RX   PubMed=9682272;
RA   Lin H.J., Probst-Hensch N.M., Hughes N.C., Sakamoto G.T., Louie A.D.,
RA   Kau I.H., Lin B.K., Lee D.B., Lin J., Frankl H.D., Lee E.R., Hardy S.,
RA   Grant D.M., Haile R.W.;
RT   "Variants of N-acetyltransferase NAT1 and a case-control study of
RT   colorectal adenomas.";
RL   Pharmacogenetics 8:269-281(1998).
CC   -!- FUNCTION: Participates in the detoxification of a plethora of
CC       hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation
CC       of various arylamine and heterocyclic amine substrates and is able
CC       to bioactivate several known carcinogens.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + an arylamine = CoA + an N-
CC       acetylarylamine.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- POLYMORPHISM: N-acetylation polymorphism is determined by a low or
CC       high NAT activity in liver and has been implicated in the action
CC       and toxicity of amine-containing drugs. Slow acetylation genotypes
CC       have been associated with significant lung cancer risk. Candidate
CC       risk factor for susceptibility to neural tube defects. The NAT1*10
CC       allele has been associated with increased risk of colon and
CC       urinary bladder cancers and with higher levels of N-
CC       acetyltransferase activity and DNA adducts in aromatic amine tumor
CC       target organs such as colon and urinary bladder (PubMed:7585580).
CC       {ECO:0000269|PubMed:7585580}.
CC   -!- MISCELLANEOUS: NAT1 was historically considered to be monomorphic
CC       in nature but reports of allelic variations at the NAT1 locus
CC       suggest that it is a polymorphically expressed enzyme.
CC   -!- SIMILARITY: Belongs to the arylamine N-acetyltransferase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: The allelic variation Ile-149 designated as NAT1*17 is
CC       part of the NAT1*11 allelic variation as reported by the
CC       nomenclature committee. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NAT; Note=NAT alleles;
CC       URL="http://nat.mbg.duth.gr/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nat1/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=NAT1";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NAT1ID41497ch8p22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17059; CAA34905.1; -; Genomic_DNA.
DR   EMBL; D90041; BAA14095.1; -; mRNA.
DR   EMBL; AF032677; AAB86878.1; -; Genomic_DNA.
DR   EMBL; AF032678; AAB86879.1; -; Genomic_DNA.
DR   EMBL; U80835; AAB62398.1; -; Genomic_DNA.
DR   EMBL; AF008204; AAB84384.1; -; Genomic_DNA.
DR   EMBL; AF071552; AAC24712.1; -; Genomic_DNA.
DR   EMBL; AF067408; AAC24707.1; -; Genomic_DNA.
DR   EMBL; AF082903; AAD13343.1; -; Genomic_DNA.
DR   EMBL; AF082904; AAC32388.1; -; Genomic_DNA.
DR   EMBL; AJ278017; CAC01128.1; -; Genomic_DNA.
DR   EMBL; AJ307007; CAC38345.1; -; Genomic_DNA.
DR   EMBL; DQ305816; ABC26192.1; -; Genomic_DNA.
DR   EMBL; DQ305817; ABC26193.1; -; Genomic_DNA.
DR   EMBL; DQ305818; ABC26194.1; -; Genomic_DNA.
DR   EMBL; DQ305819; ABC26195.1; -; Genomic_DNA.
DR   EMBL; DQ305820; ABC26196.1; -; Genomic_DNA.
DR   EMBL; DQ305821; ABC26197.1; -; Genomic_DNA.
DR   EMBL; DQ305822; ABC26198.1; -; Genomic_DNA.
DR   EMBL; DQ305823; ABC26199.1; -; Genomic_DNA.
DR   EMBL; DQ305824; ABC26200.1; -; Genomic_DNA.
DR   EMBL; DQ305825; ABC26201.1; -; Genomic_DNA.
DR   EMBL; DQ305826; ABC26202.1; -; Genomic_DNA.
DR   EMBL; DQ305827; ABC26203.1; -; Genomic_DNA.
DR   EMBL; DQ305828; ABC26204.1; -; Genomic_DNA.
DR   EMBL; DQ305829; ABC26205.1; -; Genomic_DNA.
DR   EMBL; DQ305830; ABC26206.1; -; Genomic_DNA.
DR   EMBL; DQ305831; ABC26207.1; -; Genomic_DNA.
DR   EMBL; DQ305832; ABC26208.1; -; Genomic_DNA.
DR   EMBL; DQ305833; ABC26209.1; -; Genomic_DNA.
DR   EMBL; DQ305834; ABC26210.1; -; Genomic_DNA.
DR   EMBL; DQ305835; ABC26211.1; -; Genomic_DNA.
DR   EMBL; DQ305836; ABC26212.1; -; Genomic_DNA.
DR   EMBL; DQ305837; ABC26213.1; -; Genomic_DNA.
DR   EMBL; DQ305838; ABC26214.1; -; Genomic_DNA.
DR   EMBL; DQ305839; ABC26215.1; -; Genomic_DNA.
DR   EMBL; DQ305840; ABC26216.1; -; Genomic_DNA.
DR   EMBL; DQ305841; ABC26217.1; -; Genomic_DNA.
DR   EMBL; DQ305842; ABC26218.1; -; Genomic_DNA.
DR   EMBL; DQ305843; ABC26219.1; -; Genomic_DNA.
DR   EMBL; DQ305844; ABC26220.1; -; Genomic_DNA.
DR   EMBL; DQ305845; ABC26221.1; -; Genomic_DNA.
DR   EMBL; DQ305846; ABC26222.1; -; Genomic_DNA.
DR   EMBL; DQ305847; ABC26223.1; -; Genomic_DNA.
DR   EMBL; DQ305848; ABC26224.1; -; Genomic_DNA.
DR   EMBL; DQ305849; ABC26225.1; -; Genomic_DNA.
DR   EMBL; DQ305850; ABC26226.1; -; Genomic_DNA.
DR   EMBL; DQ305851; ABC26227.1; -; Genomic_DNA.
DR   EMBL; DQ305852; ABC26228.1; -; Genomic_DNA.
DR   EMBL; DQ305853; ABC26229.1; -; Genomic_DNA.
DR   EMBL; DQ305854; ABC26230.1; -; Genomic_DNA.
DR   EMBL; DQ305855; ABC26231.1; -; Genomic_DNA.
DR   EMBL; DQ305856; ABC26232.1; -; Genomic_DNA.
DR   EMBL; DQ305857; ABC26233.1; -; Genomic_DNA.
DR   EMBL; DQ305858; ABC26234.1; -; Genomic_DNA.
DR   EMBL; DQ305859; ABC26235.1; -; Genomic_DNA.
DR   EMBL; DQ305860; ABC26236.1; -; Genomic_DNA.
DR   EMBL; DQ305861; ABC26237.1; -; Genomic_DNA.
DR   EMBL; DQ305862; ABC26238.1; -; Genomic_DNA.
DR   EMBL; DQ305863; ABC26239.1; -; Genomic_DNA.
DR   EMBL; DQ305864; ABC26240.1; -; Genomic_DNA.
DR   EMBL; DQ305865; ABC26241.1; -; Genomic_DNA.
DR   EMBL; DQ305866; ABC26242.1; -; Genomic_DNA.
DR   EMBL; DQ305867; ABC26243.1; -; Genomic_DNA.
DR   EMBL; DQ305868; ABC26244.1; -; Genomic_DNA.
DR   EMBL; DQ305869; ABC26245.1; -; Genomic_DNA.
DR   EMBL; DQ305870; ABC26246.1; -; Genomic_DNA.
DR   EMBL; DQ305871; ABC26247.1; -; Genomic_DNA.
DR   EMBL; DQ305872; ABC26248.1; -; Genomic_DNA.
DR   EMBL; DQ305873; ABC26249.1; -; Genomic_DNA.
DR   EMBL; DQ305874; ABC26250.1; -; Genomic_DNA.
DR   EMBL; DQ305875; ABC26251.1; -; Genomic_DNA.
DR   EMBL; DQ305876; ABC26252.1; -; Genomic_DNA.
DR   EMBL; DQ305877; ABC26253.1; -; Genomic_DNA.
DR   EMBL; DQ305878; ABC26254.1; -; Genomic_DNA.
DR   EMBL; DQ305879; ABC26255.1; -; Genomic_DNA.
DR   EMBL; DQ305880; ABC26256.1; -; Genomic_DNA.
DR   EMBL; DQ305881; ABC26257.1; -; Genomic_DNA.
DR   EMBL; DQ305882; ABC26258.1; -; Genomic_DNA.
DR   EMBL; DQ305883; ABC26259.1; -; Genomic_DNA.
DR   EMBL; DQ305884; ABC26260.1; -; Genomic_DNA.
DR   EMBL; DQ305885; ABC26261.1; -; Genomic_DNA.
DR   EMBL; DQ305886; ABC26262.1; -; Genomic_DNA.
DR   EMBL; DQ305887; ABC26263.1; -; Genomic_DNA.
DR   EMBL; DQ305888; ABC26264.1; -; Genomic_DNA.
DR   EMBL; DQ305889; ABC26265.1; -; Genomic_DNA.
DR   EMBL; DQ305890; ABC26266.1; -; Genomic_DNA.
DR   EMBL; DQ305891; ABC26267.1; -; Genomic_DNA.
DR   EMBL; DQ305892; ABC26268.1; -; Genomic_DNA.
DR   EMBL; DQ305893; ABC26269.1; -; Genomic_DNA.
DR   EMBL; DQ305894; ABC26270.1; -; Genomic_DNA.
DR   EMBL; DQ305895; ABC26271.1; -; Genomic_DNA.
DR   EMBL; DQ305896; ABC26272.1; -; Genomic_DNA.
DR   EMBL; DQ305897; ABC26273.1; -; Genomic_DNA.
DR   EMBL; DQ305898; ABC26274.1; -; Genomic_DNA.
DR   EMBL; DQ305899; ABC26275.1; -; Genomic_DNA.
DR   EMBL; DQ305900; ABC26276.1; -; Genomic_DNA.
DR   EMBL; DQ305901; ABC26277.1; -; Genomic_DNA.
DR   EMBL; DQ305902; ABC26278.1; -; Genomic_DNA.
DR   EMBL; DQ305903; ABC26279.1; -; Genomic_DNA.
DR   EMBL; DQ305904; ABC26280.1; -; Genomic_DNA.
DR   EMBL; DQ305905; ABC26281.1; -; Genomic_DNA.
DR   EMBL; DQ305906; ABC26282.1; -; Genomic_DNA.
DR   EMBL; DQ305907; ABC26283.1; -; Genomic_DNA.
DR   EMBL; DQ305908; ABC26284.1; -; Genomic_DNA.
DR   EMBL; DQ305909; ABC26285.1; -; Genomic_DNA.
DR   EMBL; DQ305910; ABC26286.1; -; Genomic_DNA.
DR   EMBL; DQ305911; ABC26287.1; -; Genomic_DNA.
DR   EMBL; DQ305912; ABC26288.1; -; Genomic_DNA.
DR   EMBL; DQ305913; ABC26289.1; -; Genomic_DNA.
DR   EMBL; DQ305914; ABC26290.1; -; Genomic_DNA.
DR   EMBL; DQ305915; ABC26291.1; -; Genomic_DNA.
DR   EMBL; DQ305916; ABC26292.1; -; Genomic_DNA.
DR   EMBL; DQ305917; ABC26293.1; -; Genomic_DNA.
DR   EMBL; DQ305918; ABC26294.1; -; Genomic_DNA.
DR   EMBL; DQ305919; ABC26295.1; -; Genomic_DNA.
DR   EMBL; DQ305920; ABC26296.1; -; Genomic_DNA.
DR   EMBL; DQ305921; ABC26297.1; -; Genomic_DNA.
DR   EMBL; DQ305922; ABC26298.1; -; Genomic_DNA.
DR   EMBL; DQ305923; ABC26299.1; -; Genomic_DNA.
DR   EMBL; DQ305924; ABC26300.1; -; Genomic_DNA.
DR   EMBL; DQ305925; ABC26301.1; -; Genomic_DNA.
DR   EMBL; DQ305926; ABC26302.1; -; Genomic_DNA.
DR   EMBL; DQ305927; ABC26303.1; -; Genomic_DNA.
DR   EMBL; DQ305928; ABC26304.1; -; Genomic_DNA.
DR   EMBL; DQ305929; ABC26305.1; -; Genomic_DNA.
DR   EMBL; DQ305930; ABC26306.1; -; Genomic_DNA.
DR   EMBL; DQ305931; ABC26307.1; -; Genomic_DNA.
DR   EMBL; DQ305932; ABC26308.1; -; Genomic_DNA.
DR   EMBL; DQ305933; ABC26309.1; -; Genomic_DNA.
DR   EMBL; DQ305934; ABC26310.1; -; Genomic_DNA.
DR   EMBL; DQ305935; ABC26311.1; -; Genomic_DNA.
DR   EMBL; DQ305936; ABC26312.1; -; Genomic_DNA.
DR   EMBL; DQ305937; ABC26313.1; -; Genomic_DNA.
DR   EMBL; DQ305938; ABC26314.1; -; Genomic_DNA.
DR   EMBL; DQ305939; ABC26315.1; -; Genomic_DNA.
DR   EMBL; DQ305940; ABC26316.1; -; Genomic_DNA.
DR   EMBL; DQ305941; ABC26317.1; -; Genomic_DNA.
DR   EMBL; DQ305942; ABC26318.1; -; Genomic_DNA.
DR   EMBL; DQ305943; ABC26319.1; -; Genomic_DNA.
DR   EMBL; DQ305944; ABC26320.1; -; Genomic_DNA.
DR   EMBL; DQ305945; ABC26321.1; -; Genomic_DNA.
DR   EMBL; DQ305946; ABC26322.1; -; Genomic_DNA.
DR   EMBL; DQ305947; ABC26323.1; -; Genomic_DNA.
DR   EMBL; DQ305948; ABC26324.1; -; Genomic_DNA.
DR   EMBL; DQ305949; ABC26325.1; -; Genomic_DNA.
DR   EMBL; DQ305950; ABC26326.1; -; Genomic_DNA.
DR   EMBL; DQ305951; ABC26327.1; -; Genomic_DNA.
DR   EMBL; DQ305952; ABC26328.1; -; Genomic_DNA.
DR   EMBL; DQ305953; ABC26329.1; -; Genomic_DNA.
DR   EMBL; DQ305954; ABC26330.1; -; Genomic_DNA.
DR   EMBL; DQ305955; ABC26331.1; -; Genomic_DNA.
DR   EMBL; DQ305956; ABC26332.1; -; Genomic_DNA.
DR   EMBL; DQ305957; ABC26333.1; -; Genomic_DNA.
DR   EMBL; DQ305958; ABC26334.1; -; Genomic_DNA.
DR   EMBL; DQ305959; ABC26335.1; -; Genomic_DNA.
DR   EMBL; DQ305960; ABC26336.1; -; Genomic_DNA.
DR   EMBL; DQ305961; ABC26337.1; -; Genomic_DNA.
DR   EMBL; DQ305962; ABC26338.1; -; Genomic_DNA.
DR   EMBL; DQ305963; ABC26339.1; -; Genomic_DNA.
DR   EMBL; DQ305964; ABC26340.1; -; Genomic_DNA.
DR   EMBL; DQ305965; ABC26341.1; -; Genomic_DNA.
DR   EMBL; DQ305966; ABC26342.1; -; Genomic_DNA.
DR   EMBL; DQ305967; ABC26343.1; -; Genomic_DNA.
DR   EMBL; DQ305968; ABC26344.1; -; Genomic_DNA.
DR   EMBL; DQ305969; ABC26345.1; -; Genomic_DNA.
DR   EMBL; DQ305970; ABC26346.1; -; Genomic_DNA.
DR   EMBL; DQ305971; ABC26347.1; -; Genomic_DNA.
DR   EMBL; DQ305972; ABC26348.1; -; Genomic_DNA.
DR   EMBL; DQ305973; ABC26349.1; -; Genomic_DNA.
DR   EMBL; DQ305974; ABC26350.1; -; Genomic_DNA.
DR   EMBL; DQ305975; ABC26351.1; -; Genomic_DNA.
DR   EMBL; AK290912; BAF83601.1; -; mRNA.
DR   EMBL; AY338489; AAP88036.1; -; Genomic_DNA.
DR   EMBL; AY800271; AAV50002.1; -; Genomic_DNA.
DR   EMBL; BC047666; AAH47666.1; -; mRNA.
DR   EMBL; M75164; AAA59905.1; -; Genomic_DNA.
DR   CCDS; CCDS6007.1; -.
DR   PIR; A34585; A34585.
DR   RefSeq; NP_000653.3; NM_000662.7.
DR   RefSeq; NP_001153642.1; NM_001160170.3.
DR   RefSeq; NP_001153643.1; NM_001160171.3.
DR   RefSeq; NP_001153644.1; NM_001160172.3.
DR   RefSeq; NP_001153645.1; NM_001160173.3.
DR   RefSeq; NP_001153646.1; NM_001160174.2.
DR   RefSeq; NP_001153651.1; NM_001160179.2.
DR   RefSeq; XP_006716473.1; XM_006716410.3.
DR   RefSeq; XP_011542991.1; XM_011544689.2.
DR   UniGene; Hs.2; -.
DR   UniGene; Hs.591847; -.
DR   PDB; 2DSS; Model; -; @=1-290.
DR   PDB; 2GWU; Model; -; A=1-290.
DR   PDB; 2IJA; X-ray; 1.70 A; A=2-290.
DR   PDB; 2PQT; X-ray; 1.78 A; A=2-290.
DR   PDBsum; 2DSS; -.
DR   PDBsum; 2GWU; -.
DR   PDBsum; 2IJA; -.
DR   PDBsum; 2PQT; -.
DR   ProteinModelPortal; P18440; -.
DR   SMR; P18440; -.
DR   BioGrid; 106527; 2.
DR   IntAct; P18440; 1.
DR   STRING; 9606.ENSP00000443194; -.
DR   BindingDB; P18440; -.
DR   ChEMBL; CHEMBL5101; -.
DR   DrugBank; DB01015; Sulfamethoxazole.
DR   iPTMnet; P18440; -.
DR   PhosphoSitePlus; P18440; -.
DR   SwissPalm; P18440; -.
DR   BioMuta; NAT1; -.
DR   DMDM; 114234; -.
DR   EPD; P18440; -.
DR   MaxQB; P18440; -.
DR   PaxDb; P18440; -.
DR   PeptideAtlas; P18440; -.
DR   PRIDE; P18440; -.
DR   DNASU; 9; -.
DR   Ensembl; ENST00000307719; ENSP00000307218; ENSG00000171428.
DR   Ensembl; ENST00000517492; ENSP00000429407; ENSG00000171428.
DR   Ensembl; ENST00000518029; ENSP00000428270; ENSG00000171428.
DR   Ensembl; ENST00000520546; ENSP00000429341; ENSG00000171428.
DR   Ensembl; ENST00000541942; ENSP00000440900; ENSG00000171428.
DR   GeneID; 9; -.
DR   KEGG; hsa:9; -.
DR   UCSC; uc003wyq.4; human.
DR   CTD; 9; -.
DR   DisGeNET; 9; -.
DR   GeneCards; NAT1; -.
DR   HGNC; HGNC:7645; NAT1.
DR   HPA; CAB017782; -.
DR   HPA; HPA043704; -.
DR   MalaCards; NAT1; -.
DR   MIM; 108345; gene.
DR   neXtProt; NX_P18440; -.
DR   OpenTargets; ENSG00000171428; -.
DR   PharmGKB; PA17; -.
DR   eggNOG; ENOG410IFD6; Eukaryota.
DR   eggNOG; COG2162; LUCA.
DR   GeneTree; ENSGT00390000012054; -.
DR   HOGENOM; HOG000205435; -.
DR   HOVERGEN; HBG000165; -.
DR   InParanoid; P18440; -.
DR   KO; K00622; -.
DR   PhylomeDB; P18440; -.
DR   BRENDA; 2.3.1.5; 2681.
DR   BRENDA; 2.3.1.88; 2681.
DR   Reactome; R-HSA-156582; Acetylation.
DR   ChiTaRS; NAT1; human.
DR   EvolutionaryTrace; P18440; -.
DR   GeneWiki; N-acetyltransferase_1; -.
DR   GenomeRNAi; 9; -.
DR   PRO; PR:P18440; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000171428; -.
DR   CleanEx; HS_NAT1; -.
DR   ExpressionAtlas; P18440; baseline and differential.
DR   Genevisible; P18440; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004060; F:arylamine N-acetyltransferase activity; TAS:Reactome.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR001447; Arylamine_N-AcTrfase.
DR   PANTHER; PTHR11786; PTHR11786; 1.
DR   Pfam; PF00797; Acetyltransf_2; 1.
DR   PRINTS; PR01543; ANATRNSFRASE.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Complete proteome;
KW   Cytoplasm; Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    290       Arylamine N-acetyltransferase 1.
FT                                /FTId=PRO_0000107904.
FT   REGION      106    107       Substrate binding.
FT   ACT_SITE     68     68       Acyl-thioester intermediate.
FT   ACT_SITE    107    107
FT   ACT_SITE    122    122
FT   BINDING     103    103       Coenzyme A. {ECO:0000250}.
FT   BINDING     104    104       Coenzyme A; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     208    208       Coenzyme A. {ECO:0000250}.
FT   BINDING     214    214       Coenzyme A. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   VARIANT      64     64       R -> W (in allele NAT1*17; a slow
FT                                acetylator; has defective enzyme
FT                                activity; dbSNP:rs56379106).
FT                                {ECO:0000269|PubMed:9511183}.
FT                                /FTId=VAR_004606.
FT   VARIANT     117    117       R -> T (in allele NAT1*5;
FT                                dbSNP:rs55641436).
FT                                {ECO:0000269|PubMed:1968463}.
FT                                /FTId=VAR_009510.
FT   VARIANT     149    149       V -> I (in allele NAT1*11; catalyzes the
FT                                N-acetylation of aromatic amines and the
FT                                O- and N,O-acetylation of their N-
FT                                hydroxylated metabolites at rates up to
FT                                2-fold higher; dbSNP:rs4987076).
FT                                {ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|PubMed:8442668,
FT                                ECO:0000269|PubMed:9168895,
FT                                ECO:0000269|Ref.12, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_004607.
FT   VARIANT     166    167       RE -> TQ (in allele NAT1*5;
FT                                dbSNP:rs72554608).
FT                                /FTId=VAR_009511.
FT   VARIANT     187    187       R -> Q (in allele NAT1*14; a slow
FT                                acetylator; dbSNP:rs4986782).
FT                                {ECO:0000269|PubMed:9511182,
FT                                ECO:0000269|PubMed:9511183}.
FT                                /FTId=VAR_009069.
FT   VARIANT     205    205       M -> V (in allele NAT1*21;
FT                                dbSNP:rs72554609).
FT                                /FTId=VAR_009070.
FT   VARIANT     207    207       T -> I (in dbSNP:rs4987195).
FT                                /FTId=VAR_020384.
FT   VARIANT     214    214       S -> A (in allele NAT1*11;
FT                                dbSNP:rs4986783).
FT                                {ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|PubMed:8442668,
FT                                ECO:0000269|PubMed:9168895,
FT                                ECO:0000269|Ref.12, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_009071.
FT   VARIANT     251    251       D -> V (in allele NAT1*22;
FT                                dbSNP:rs56172717).
FT                                /FTId=VAR_009072.
FT   VARIANT     261    261       E -> K (in allele NAT1*24;
FT                                dbSNP:rs72554610).
FT                                /FTId=VAR_009073.
FT   VARIANT     263    263       I -> V (in allele NAT1*25;
FT                                dbSNP:rs72554611).
FT                                /FTId=VAR_009074.
FT   MUTAGEN      64     64       R->A,M,Q,K: Reduced enzymatic activity.
FT                                {ECO:0000269|PubMed:9173883}.
FT   HELIX         2      9       {ECO:0000244|PDB:2IJA}.
FT   HELIX        21     34       {ECO:0000244|PDB:2IJA}.
FT   HELIX        42     44       {ECO:0000244|PDB:2IJA}.
FT   HELIX        52     60       {ECO:0000244|PDB:2IJA}.
FT   HELIX        68     82       {ECO:0000244|PDB:2IJA}.
FT   STRAND       85     95       {ECO:0000244|PDB:2IJA}.
FT   TURN         96     99       {ECO:0000244|PDB:2IJA}.
FT   STRAND      107    114       {ECO:0000244|PDB:2IJA}.
FT   STRAND      117    121       {ECO:0000244|PDB:2IJA}.
FT   STRAND      123    125       {ECO:0000244|PDB:2PQT}.
FT   HELIX       127    129       {ECO:0000244|PDB:2IJA}.
FT   STRAND      142    144       {ECO:0000244|PDB:2IJA}.
FT   STRAND      149    155       {ECO:0000244|PDB:2IJA}.
FT   STRAND      158    164       {ECO:0000244|PDB:2IJA}.
FT   STRAND      167    169       {ECO:0000244|PDB:2IJA}.
FT   HELIX       173    175       {ECO:0000244|PDB:2IJA}.
FT   STRAND      185    192       {ECO:0000244|PDB:2IJA}.
FT   HELIX       199    202       {ECO:0000244|PDB:2IJA}.
FT   HELIX       203    211       {ECO:0000244|PDB:2IJA}.
FT   HELIX       216    219       {ECO:0000244|PDB:2IJA}.
FT   STRAND      222    226       {ECO:0000244|PDB:2IJA}.
FT   STRAND      228    235       {ECO:0000244|PDB:2IJA}.
FT   STRAND      238    243       {ECO:0000244|PDB:2IJA}.
FT   STRAND      247    257       {ECO:0000244|PDB:2IJA}.
FT   HELIX       260    271       {ECO:0000244|PDB:2IJA}.
SQ   SEQUENCE   290 AA;  33899 MW;  C015F7F3D4830107 CRC64;
     MDIEAYLERI GYKKSRNKLD LETLTDILQH QIRAVPFENL NIHCGDAMDL GLEAIFDQVV
     RRNRGGWCLQ VNHLLYWALT TIGFETTMLG GYVYSTPAKK YSTGMIHLLL QVTIDGRNYI
     VDAGFGRSYQ MWQPLELISG KDQPQVPCVF RLTEENGFWY LDQIRREQYI PNEEFLHSDL
     LEDSKYRKIY SFTLKPRTIE DFESMNTYLQ TSPSSVFTSK SFCSLQTPDG VHCLVGFTLT
     HRRFNYKDNT DLIEFKTLSE EEIEKVLKNI FNISLQRKLV PKHGDRFFTI
//
